Prospect

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameProspect
Drug Alias Namedystrophin gene modulators (Prosensa)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionDMD gene modulators
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioMarin Nederland BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioMarin Nederland BV
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksN/A